rs147992416
Variant names:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_016234.4(ACSL5):c.135G>A(p.Ser45Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000411 in 1,614,080 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00041 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00041 ( 3 hom. )
Consequence
ACSL5
NM_016234.4 synonymous
NM_016234.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.77
Genes affected
ACSL5 (HGNC:16526): (acyl-CoA synthetase long chain family member 5) The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme is highly expressed in uterus and spleen, and in trace amounts in normal brain, but has markedly increased levels in malignant gliomas. This gene functions in mediating fatty acid-induced glioma cell growth. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 10-112376444-G-A is Benign according to our data. Variant chr10-112376444-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3388166.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACSL5 | NM_203379.2 | c.-30+2175G>A | intron_variant | Intron 1 of 20 | ENST00000354655.9 | NP_976313.1 | ||
ACSL5 | NM_016234.4 | c.135G>A | p.Ser45Ser | synonymous_variant | Exon 1 of 21 | NP_057318.2 | ||
ACSL5 | NM_001387037.1 | c.135G>A | p.Ser45Ser | synonymous_variant | Exon 1 of 20 | NP_001373966.1 | ||
ACSL5 | NM_203380.2 | c.-30+902G>A | intron_variant | Intron 1 of 20 | NP_976314.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000408 AC: 62AN: 152112Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
62
AN:
152112
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000817 AC: 205AN: 251056Hom.: 2 AF XY: 0.000729 AC XY: 99AN XY: 135766
GnomAD3 exomes
AF:
AC:
205
AN:
251056
Hom.:
AF XY:
AC XY:
99
AN XY:
135766
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000411 AC: 601AN: 1461850Hom.: 3 Cov.: 31 AF XY: 0.000403 AC XY: 293AN XY: 727228
GnomAD4 exome
AF:
AC:
601
AN:
1461850
Hom.:
Cov.:
31
AF XY:
AC XY:
293
AN XY:
727228
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000407 AC: 62AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.000497 AC XY: 37AN XY: 74432
GnomAD4 genome
AF:
AC:
62
AN:
152230
Hom.:
Cov.:
32
AF XY:
AC XY:
37
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
ACSL5: BP4, BP7 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at